Cargando…

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma

Detalles Bibliográficos
Autores principales:	Diefenbach, Russell J, Lee, Jenny H, Rizos, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475794/ https://www.ncbi.nlm.nih.gov/pubmed/32922728 http://dx.doi.org/10.2217/mmt-2020-0010

Ejemplares similares

Liquid biomarkers in melanoma: detection and discovery
por: Lim, Su Yin, et al.
Publicado: (2018)

Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C Inhibition
por: Park, John J., et al.
Publicado: (2021)

Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2022)

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
por: Diefenbach, Russell J., et al.
Publicado: (2019)

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2020)

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
por: Gray, Elin S., et al.
Publicado: (2015)

Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
por: Salvianti, Francesca, et al.
Publicado: (2016)

A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
por: Guo, Wenna, et al.
Publicado: (2019)

Oncolytic virotherapy using herpes simplex virus: how far have we come?
por: Sokolowski, Nicolas AS, et al.
Publicado: (2015)

Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling
por: Park, John J., et al.
Publicado: (2022)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016)

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
por: Herbreteau, Guillaume, et al.
Publicado: (2018)

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018)

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021)

Circulating mitochondrial DNA as a biomarker for lung cancer screening
por: von Itzstein, Mitchell S., et al.
Publicado: (2022)

Clinical Application of the Unifying Concept of Cutaneous Melanoma
por: Roncati, Luca, et al.
Publicado: (2017)

Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients
por: Shoji, Yoshiaki, et al.
Publicado: (2022)

Circulating Tumor DNA Testing for Liver Cancer
por: Furtado, Larissa V., et al.
Publicado: (2015)

Characterization of DNA Methylation in Circulating Tumor Cells
por: Pixberg, Constantin F., et al.
Publicado: (2015)

Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors
por: Draškovič, Tina, et al.
Publicado: (2023)

Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
por: Micevic, Goran, et al.
Publicado: (2017)

PTPRC functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma
por: Li, Xuemei, et al.
Publicado: (2023)

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients
por: Lee, J H, et al.
Publicado: (2019)

On the clinical significance of cutaneous melanoma's precursors
por: Noto, Giuseppe
Publicado: (2012)

Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma
por: Kurtz, David M.
Publicado: (2021)

Biomarkers and the Fontan Circulation
por: Schumacher, Kurt R., et al.
Publicado: (2016)

Single-Cell Identification of Melanoma Biomarkers in Circulating Tumor Cells
por: Fankhauser, Reilly, et al.
Publicado: (2022)

Circulating miRNAs as Tumor Biomarkers: A Preface to the Special Issue
por: Markou, Athina N.
Publicado: (2020)

Genome-wide methylation analysis of circulating tumor DNA: A new biomarker for recurrent glioblastom
por: Dai, Lin, et al.
Publicado: (2023)

Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients
por: Gorges, Katharina, et al.
Publicado: (2019)

Current Trends in Circulating Biomarkers for Melanoma Detection
por: Huang, Nancy, et al.
Publicado: (2022)

Recent Advances in Liquid Biopsy Based on Circulating Tumor DNA
por: Sakuma, Yu, et al.
Publicado: (2019)

Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer
por: Hai, Luo, et al.
Publicado: (2022)

Circulating Cancer Biomarkers
por: Lokshin, Anna, et al.
Publicado: (2021)

Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden
por: Lin, Jiaqiong, et al.
Publicado: (2020)

The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022)

Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma
por: Wouters, Jasper, et al.
Publicado: (2017)

High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China
por: Li, Jisen, et al.
Publicado: (2018)

Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma
por: Bustamante, Prisca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kpbk2eahaq5jgtn1d9c9gt9ieh